Ticker name:RGEN REPLIGEN CORP
Sector: Health CareSEC description: Biological Products, (No Diagnostic Substances)Country: United States
- steady in 2021
Last close 113.88$
Market Cap 6.4B
Price Return
- 90d
- -29.87%
- YTD
- -30.5%
- 1Y
- -18.27%
- 3Y
- -34.57%
- 5Y
- -45.1%
Base metrics
Largest 20 companies In Biological Products, (No Diagnostic Substances)
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | AMGN | AMGEN INC | 187B | 347.8$ | |
| 2 | GILD | GILEAD SCIENCES, INC. | 170B | 137.21$ | |
| 3 | BIIB | BIOGEN INC. | 27B | 181.46$ | |
| 4 | MRNA | Moderna, Inc. | 20B | 51.38$ | |
| 5 | RVMD | Revolution Medicines, Inc. | 19B | 95.78$ | |
| 6 | NBIX | NEUROCRINE BIOSCIENCES INC | 13B | 127.68$ | |
| 7 | EXEL | EXELIXIS, INC. | 11B | 41.27$ | |
| 8 | IBRX | ImmunityBio, Inc. | 8.7B | 8.47$ | |
| 9 | QGEN | QIAGEN N.V. | 8.2B | 39.93$ | |
| 10 | TECH | BIO-TECHNE Corp | 8.1B | 51.48$ | |
| 11 | PCVX | Vaxcyte, Inc. | 7.9B | 54.72$ | |
| 12 | HALO | HALOZYME THERAPEUTICS, INC. | 7.5B | 63.43$ | |
| 13 | KRYS | Krystal Biotech, Inc. | 7.4B | 251.68$ | |
| 14 | ACLX | Arcellx, Inc. | 6.7B | 114.77$ | |
| 15 | RGEN | REPLIGEN CORP | 6.4B | 113.88$ | |
| 16 | KYMR | Kymera Therapeutics, Inc. | 6.4B | 77.91$ | |
| 17 | CGON | CG Oncology, Inc. | 5.5B | 65.08$ | |
| 18 | SRRK | Scholar Rock Holding Corp | 5.1B | 44.64$ | |
| 19 | IMVT | Immunovant, Inc. | 4.7B | 22.98$ | |
| 20 | APGE | Apogee Therapeutics, Inc. | 4.6B | 66.04$ |